The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)

NCT07065968 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Immune Thrombocytopenia (ITP)

Interventions

DRUG: Teriflunomide
DRUG: Dexamethasone

Sponsor

Peking University People's Hospital

Collaborators

[object Object]
[object Object]